| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034852752 |
| P356 | DOI | 10.1016/S1091-255X(99)80022-5 |
| P698 | PubMed publication ID | 10457335 |
| P2093 | author name string | W Zhou | |
| R H Bell | |||
| R Moonka | |||
| P2860 | cites work | Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway | Q68219906 |
| Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990 | Q68581002 | ||
| Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice | Q69059131 | ||
| Role of cholecystokinin in regulation of gastrointestinal motor functions | Q69371154 | ||
| Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study | Q71832688 | ||
| Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors | Q72896670 | ||
| Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer | Q72966853 | ||
| Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor | Q24310716 | ||
| Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion | Q34113980 | ||
| Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. | Q34244327 | ||
| Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas | Q36421669 | ||
| Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma | Q37370473 | ||
| Diet and pancreatic cancer: a case-control study | Q38592134 | ||
| Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors | Q40393295 | ||
| Cholecystokinin receptors and PANC-1 human pancreatic cancer cells | Q41544608 | ||
| Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice | Q41641498 | ||
| Establishment of a New Human Pancreatic Adenocarcinoma Cell Line, MDAPanc-3 | Q41757507 | ||
| Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice | Q41936517 | ||
| Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model | Q42374570 | ||
| Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach | Q42436734 | ||
| Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones | Q42523059 | ||
| Cancer statistics, 1994. | Q43560974 | ||
| Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation | Q44021306 | ||
| Inhibition of Cholecystokinin-Stimulated Pancreaticobiliary Output in Man by the Cholecystokinin Receptor Antagonist MK-329 | Q45116714 | ||
| Pancreas cancer and smoking, beverage consumption, and past medical history. | Q45156740 | ||
| Differential Gene Expression of CCK(A) and CCK(B) Receptors in the Rat Brain | Q47818476 | ||
| Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study | Q49035917 | ||
| Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer | Q67541967 | ||
| P433 | issue | 2 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| cholecystokinin | Q60315441 | ||
| P304 | page(s) | 134-140 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
| P1476 | title | Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer | |
| P478 | volume | 3 |
| Q48195010 | CCK1 receptor is involved in the regulation of protein lysine acetylation in GBC-SD cells and gallbladder carcinoma. |
| Q33849781 | Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease? |
| Q37672085 | Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway |
| Q41178228 | Expression of cholecystokinin receptors in colon cancer and the clinical correlation in Taiwan |
| Q33876919 | Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas |
| Q39721404 | Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease. |
| Q90639198 | Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes |
| Q33953508 | Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together |
| Q35104427 | Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders |
| Q37650725 | The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers |
Search more.